MYELODYSPLASTIC SYNDROME
Clinical trials for MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy trial aims to boost red blood cells in blood disorder patients
Disease control Not yet recruitingThis study is testing whether combining the drug luspatercept with one of two other medications works better than luspatercept alone for treating anemia in people with lower-risk myelodysplastic syndrome (MDS). The main goal is to see if these combinations help patients make more…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 18:40 UTC
-
New 'Living Drug' trial targets tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study testing a new type of CAR T-cell therapy for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, genetically…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims to knock out tough blood cancers
Disease control Not yet recruitingThis study is testing if adding a new drug called olutasidenib to standard treatments helps patients with certain blood cancers. It is for adults newly diagnosed with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) who have a specific genetic change called an IDH1 …
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a Donor's workout help beat leukemia? new trial tests Exercise-Powered cells
Disease control Not yet recruitingThis is a first-in-human study to see if a new type of donor cell treatment is safe and might work better than the standard. The new treatment uses immune cells collected from a related donor after they exercise, with the idea that exercise makes these 'natural killer' cells more…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Scientists hunt for a new weapon against Pre-Leukemia
Knowledge-focused Not yet recruitingThis study aims to collect blood and bone marrow samples from people with myelodysplastic syndromes (MDS) to test a potential new immunotherapy. Researchers want to see if a lab-made immune cell therapy (CAR-T cells) can effectively target and kill MDS cells by recognizing a spec…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists probe Body's natural cancer fighters in blood disease patients
Knowledge-focused Not yet recruitingThis study aims to learn more about how the body's natural killer (NK) immune cells fight blood cancers like leukemia. Researchers will collect blood and bone marrow samples from 55 adult patients with acute leukemia or myelodysplastic syndrome at diagnosis and over one year. The…
Matched conditions: MYELODYSPLASTIC SYNDROME
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC